QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.014779v1 69/1/309    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haskell, C. A. Articles by Ribeiro, S. Search for Related Content PubMed PubMed Citation Articles by Haskell, C. A. Articles by Ribeiro, S.

Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8

Departments of Immunology (C.A.H., R.H.), Molecular Pharmacology (M.L., S.R.), Cell Sciences (M.R.), Drug Metabolism and Pharmacology (L.D.), and Chemistry (I.I.), Berlex Biosciences, Richmond, California; Departamento de Inmunologiía y Oncología, Centro Nacional de Biotecnología/Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain (L.K., J.G., G.M., C.M.-A.); and Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania (M.J.B., R.W.D.)

In this study, we report the first example of a nonpeptide chemokine receptor agonist, 2-{2-[4-(3-phenoxybenzyl)piperazin-1-yl]ethoxy}ethanol (ZK 756326), for the CC chemokine receptor CCR8. ZK 756326 inhibited the binding of the CCR8 ligand I-309 (CCL1), with an IC₅₀ value of 1.8 µM. Furthermore, ZK 756326 was a full agonist of CCR8, dose-responsively eliciting an increase in intracellular calcium and cross-desensitizing the response of the receptor to CCL1. In addition, ZK 756326 stimulated extracellular acidification in cells expressing human CCR8. The ability of ZK 756326 to induce a response was receptor-specific and mediated through G_i, because it could be blocked by treatment with pertussis toxin. The CCR8 agonist activated cells expressing murine CCR8, eliciting their chemotaxis and inducing phosphorylation of extracellular signal-regulated kinase ERK1/2. Like CCL1, ZK 756326 inhibited human immunodeficiency virus (HIV) fusion of cells expressing CD4 and CCR8. Finally, unlike mCCL1, ZK 756326 bound to and activated a form of mCCR8 that was mutated to eliminate O-linked sulfation at tyrosines 14 and 15. Therefore, ZK 756326 is most probably not binding in the same manner as CCL1 but can activate the switch mechanism involved in transducing signaling events. In summary, we have identified a nonpeptide agonist of CCR8. This compound may be useful in evaluating the physiological role of CCR8 in HIV infection, as well as in the general study of CCR8 biology without the constraints inherent to the use of protein agonists such as its natural ligand.

Address correspondence to: Christopher Haskell, Berlex Biosciences, De-partment of Immunology, PO Box 4099, Richmond, CA 94804. E-mail: christopher_haskell{at}berlex.com

This article has been cited by other articles:

				E. L. Wise, C. Duchesnes, P. C. A. da Fonseca, R. A. Allen, T. J. Williams, and J. E. Pease Small Molecule Receptor Agonists and Antagonists of CCR3 Provide Insight into Mechanisms of Chemokine Receptor Activation J. Biol. Chem., September 21, 2007; 282(38): 27935 - 27943. [Abstract] [Full Text] [PDF]

				P. C. Jensen, R. Nygaard, S. Thiele, A. Elder, G. Zhu, R. Kolbeck, S. Ghosh, T. W. Schwartz, and M. M. Rosenkilde Molecular Interaction of a Potent Nonpeptide Agonist with the Chemokine Receptor CCR8 Mol. Pharmacol., August 1, 2007; 72(2): 327 - 340. [Abstract] [Full Text] [PDF]

				J. M. Fox, P. Najarro, G. L. Smith, S. Struyf, P. Proost, and J. E. Pease Structure/Function Relationships of CCR8 Agonists and Antagonists: AMINO-TERMINAL EXTENSION OF CCL1 BY A SINGLE AMINO ACID GENERATES A PARTIAL AGONIST J. Biol. Chem., December 1, 2006; 281(48): 36652 - 36661. [Abstract] [Full Text] [PDF]